Page last updated: 2024-09-05

sb 216763 and Blood Poisoning

sb 216763 has been researched along with Blood Poisoning in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, DA; Bauer, I; Collin, M; Dugo, L; Foster, SJ; Louhelainen, M; Mervaala, E; Patel, NS; Thiemermann, C; Yaqoob, MM	1

Other Studies

1 other study(ies) available for sb 216763 and Blood Poisoning

Article	Year
Inhibiting glycogen synthase kinase 3beta in sepsis. Novartis Foundation symposium, 2007, Volume: 280 Topics: Alanine Transaminase; Aminophenols; Animals; Aspartate Aminotransferases; Blotting, Western; Cells, Cultured; Creatinine; Endotoxemia; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Interleukin-1beta; Kidney; Lipopolysaccharides; Male; Maleimides; Peptidoglycan; Phosphorylation; Rats; Rats, Wistar; Sepsis; Thiadiazoles; Transcription Factor RelA	2007

Article

Year

Inhibiting glycogen synthase kinase 3beta in sepsis.

Novartis Foundation symposium, 2007, Volume: 280

Topics: Alanine Transaminase; Aminophenols; Animals; Aspartate Aminotransferases; Blotting, Western; Cells, Cultured; Creatinine; Endotoxemia; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Interleukin-1beta; Kidney; Lipopolysaccharides; Male; Maleimides; Peptidoglycan; Phosphorylation; Rats; Rats, Wistar; Sepsis; Thiadiazoles; Transcription Factor RelA

2007